Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Kumarasamy, Nagalingeswaran"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-20 z 20
    Tytuł:
    Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance.
    Autorzy:
    Salata RA; Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH, 44122, USA. .
    Grinsztejn B; Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil.
    Ritz J; Harvard T.H. Chan School of Public Health, Boston, MA, USA.
    Collier AC; University of Washington, Seattle, WA, USA.
    Hogg E; Social & Scientific Systems, A DLH Company, MD, Silver Spring, USA.
    Gross R; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
    Godfrey C; NIAID, Bethesda, MD, USA.
    Kumarasamy N; YR Gaitonde Center for AIDS Research and Education, Chennai, India.
    Kanyama C; University of North Carolina Project-Malawi, Lilongwe, Malawi.
    Mellors JW; University of Pittsburgh, Pittsburgh, PA, USA.
    Wallis CL; Lancet Laboratories and BARC SA, Johannesburg, South Africa.
    Hughes MD; Harvard T.H. Chan School of Public Health, Boston, MA, USA.
    Pokaż więcej
    Corporate Authors:
    ACTG A5288 Study Team
    Źródło:
    AIDS research and therapy [AIDS Res Ther] 2023 Jan 05; Vol. 20 (1), pp. 3. Date of Electronic Publication: 2023 Jan 05.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
    MeSH Terms:
    Anti-HIV Agents*/therapeutic use
    HIV Infections*/drug therapy
    Humans ; Female ; Adult ; Male ; Reverse Transcriptase Inhibitors/therapeutic use ; Reverse Transcriptase Inhibitors/adverse effects ; Protease Inhibitors/therapeutic use ; Antiretroviral Therapy, Highly Active ; Anti-Retroviral Agents/therapeutic use ; CD4 Lymphocyte Count ; Viral Load ; RNA ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Virological failure and treatment switch after ART initiation among people living with HIV with and without routine viral load monitoring in Asia.
    Autorzy:
    Teeraananchai S; Department of Statistics, Faculty of Science, Kasetsart University, Bangkok, Thailand.; HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
    Law M; The Kirby Institute, UNSW, Sydney, New South Wales, Australia.
    Boettiger D; The Kirby Institute, UNSW, Sydney, New South Wales, Australia.
    Mata N; Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
    Gupte N; BJ Government Medical College and Sassoon General Hospital, Pune, India.
    Chan YL; Queen Elizabeth Hospital, Kowloon, Hong Kong SAR.
    Pham TN; National Hospital for Tropical Diseases, Hanoi, Vietnam.
    Chaiwarith R; Chiang Mai University - Research Institute for Health Sciences, Chiang Mai, Thailand.; Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
    Ly PS; National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia.
    Chan YJ; Taipei Veterans General Hospital, Taipei, Taiwan.
    Kiertiburanakul S; Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
    Khusuwan S; Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand.
    Zhang F; Beijing Ditan Hospital, Capital Medical University, Beijing, China.
    Yunihastuti E; Faculty of Medicine, Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
    Kumarasamy N; Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS), VHS-Infectious Diseases Medical Centre, VHS, Chennai, India.
    Pujari S; Institute of Infectious Diseases, Pune, India.
    Azwa I; University Malaya Medical Centre, Kuala Lumpur, Malaysia.
    Somia IKA; Faculty of Medicine, Udayana University & Sanglah Hospital, Bali, Indonesia.
    Tanuma J; National Center for Global Health and Medicine, Tokyo, Japan.
    Ditangco R; Research Institute for Tropical Medicine, Muntinlupa City, Philippines.
    Choi JY; Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
    Ng OT; Tan Tock Seng Hospital, Singapore.
    Do CD; Bach Mai Hospital, Hanoi, Vietnam.
    Gani Y; Hospital Sungai Buloh, Sungai Buloh, Malaysia.
    Ross J; TREAT Asia, amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
    Jiamsakul A; The Kirby Institute, UNSW, Sydney, New South Wales, Australia.
    Pokaż więcej
    Corporate Authors:
    TREAT Asia HIV Observational Database (TAHOD) of IeDEA Asia-Pacific; Department of Statistics, Faculty of Science, Kasetsart University, Bangkok, Thailand.
    Źródło:
    Journal of the International AIDS Society [J Int AIDS Soc] 2022 Aug; Vol. 25 (8), pp. e25989.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
    MeSH Terms:
    Anti-HIV Agents*
    HIV Infections*
    Adolescent ; Adult ; Antiretroviral Therapy, Highly Active ; CD4 Lymphocyte Count ; Female ; Humans ; Male ; Middle Aged ; Treatment Failure ; Viral Load
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trial.
    Autorzy:
    Avihingsanon A; HIV-NAT, Thai Red Cross AIDS Research Centre and Centre of Excellence in Tuberculosis, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
    Hughes MD; Center for Biostatistics in AIDS Research in the Department of Biostatistics, Harvard T H Chan School of Public Health, Boston, Massachusetts, USA.
    Salata R; Case Western Reserve University, Cleveland, Ohio, USA.
    Godfrey C; Division of AIDS, National Institutes of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA.
    McCarthy C; Center for Biostatistics in AIDS Research in the Department of Biostatistics, Harvard T H Chan School of Public Health, Boston, Massachusetts, USA.
    Mugyenyi P; Joint Clinical Research Center, Kampala, Uganda.
    Hogg E; Social & Scientific Systems, Inc., a DLH Holdings Company, Silver Spring, Maryland, USA.
    Gross R; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
    Cardoso SW; Instituto Nacional de Infectologia Evandro Chagas, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil.
    Bukuru A; Joint Clinical Research Center, Kampala, Uganda.
    Makanga M; Kenya Medical Research Institute/Center of Disease Control, Kisumu, Kenya.
    Badal-Aesen S; Clinical HIV Research Unit, Helen Joseph Hospital, University of Witwatersrand, Johannesburg, South Africa.
    Mave V; BJ Medical College Clinical Research Site, Pune, India.
    Ndege BW; Moi University Clinical Research Center (MUCRC) CRS, Eldoret, Kenya.
    Fontain SN; Les Centres GHESKIO Clinical Research Site, Port-au-Prince, Haiti.
    Samaneka W; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe.
    Secours R; Les Centres GHESKIO Clinical Research Site, Port-au-Prince, Haiti.
    Van Schalkwyk M; Family Centre for Research with Ubuntu (FAMCRU), Stellenbosch University, Cape Town, South Africa.
    Mngqibisa R; Durban International Clinical Research Site, King Edward Hospital, Enhancing Care Foundation, Durban, South Africa.
    Mohapi L; Soweto AIDS Clinical Trials Group, Clinical Research Site, Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
    Valencia J; Barranco Clinical Research Site, Lima, Peru.
    Sugandhavesa P; Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
    Montalban E; San Miguel Clinical Research Site, Lima, Peru.
    Munyanga C; University of North Carolina Project, Kamazu Central Hospital, Lilongwe, Malawi.
    Chagomerana M; University of North Carolina Project, Kamazu Central Hospital, Lilongwe, Malawi.
    Santos BR; Hospital Nossa Senhora da Conceicao CRS, Porto Alegre, Brazil.
    Kumarasamy N; CART, Clinical Research Site, VHS Infection Disease Medical Centre, Chennai, India.
    Kanyama C; University of North Carolina Project, Kamazu Central Hospital, Lilongwe, Malawi.
    Schooley RT; Division of Infectious Diseases, University of California, San Diego, California, USA.
    Mellors JW; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
    Wallis CL; BARC-South Africa and Lancet Laboratories, Johannesburg, South Africa.
    Collier AC; University of Washington School of Medicine, University of Washington, Seattle, Washington, USA.
    Grinsztejn B; Instituto Nacional de Infectologia Evandro Chagas, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil.
    Pokaż więcej
    Corporate Authors:
    A5288 Study team
    Źródło:
    Journal of the International AIDS Society [J Int AIDS Soc] 2022 Jun; Vol. 25 (6), pp. e25905.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Anti-HIV Agents*/therapeutic use
    HIV Infections*/drug therapy
    HIV Protease Inhibitors*/therapeutic use
    HIV-1*/genetics
    Anti-Retroviral Agents/therapeutic use ; Darunavir/therapeutic use ; Female ; Humans ; Male ; Nitriles ; Pyrimidines ; RNA/therapeutic use ; Raltegravir Potassium/adverse effects ; Ritonavir/therapeutic use ; Viral Load
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Patterns and prognosis of holding regimens for people living with HIV in Asian countries.
    Autorzy:
    Kim JH; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
    Jiamsakul A; The Kirby Institute, UNSW Sydney, Sydney, Australia.
    Kiertiburanakul S; Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
    Huy BV; National Hospital for Tropical Diseases, Hanoi, Vietnam.
    Khusuwan S; Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand.
    Kumarasamy N; Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS), VHS-Infectious Diseases Medical Centre, VHS, Chennai, India.
    Ng OT; Tan Tock Seng Hospital, Singapore, Singapore.
    Ly PS; National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia.
    Lee MP; Queen Elizabeth Hospital, Kowloon, Hong Kong SAR.
    Chan YJ; Taipei Veterans General Hospital, Taipei, Taiwan.
    Gani YM; Hospital Sungai Buloh, Sungai Buloh, Malaysia.
    Azwa I; University Malaya Medical Centre, Kuala Lumpur, Malaysia.
    Avihingsanon A; HIV-NAT/ Thai Red Cross AIDS Research Centre, Bangkok, Thailand.; Tuberculosis Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
    Merati TP; Faculty of Medicine Udayana University & Sanglah Hospital, Denpasar, Bali, Indonesia.
    Pujari S; Institute of Infectious Diseases, Pune, India.
    Chaiwarith R; Research Institute for Health Sciences, Chiang Mai, Thailand.
    Zhang F; Beijing Ditan Hospital, Capital Medical University, Beijing, China.
    Tanuma J; National Center for Global Health and Medicine, Tokyo, Japan.
    Do CD; Bach Mai Hospital, Hanoi, Vietnam.
    Ditangco R; Research Institute for Tropical Medicine, Muntinlupa City, Philippines.
    Yunihastuti E; Faculty of Medicine Universitas Indonesia-Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
    Ross J; TREAT Asia, amfAR-The Foundation for AIDS Research, Bangkok, Thailand.
    Choi JY; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
    Pokaż więcej
    Corporate Authors:
    IeDEA Asia-Pacific
    Źródło:
    PloS one [PLoS One] 2022 Mar 30; Vol. 17 (3), pp. e0264157. Date of Electronic Publication: 2022 Mar 30 (Print Publication: 2022).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Anti-HIV Agents*/pharmacology
    HIV Infections*/drug therapy
    HIV Infections*/epidemiology
    Adult ; Female ; Humans ; Lamivudine/therapeutic use ; Male ; Middle Aged ; Prognosis ; Reverse Transcriptase Inhibitors/therapeutic use ; Viral Load ; Zidovudine/therapeutic use
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    HIV treatment outcomes among people who acquired HIV via injecting drug use in the Asia-Pacific region: a longitudinal cohort study.
    Autorzy:
    Han WM; Kirby Institute, UNSW, Sydney, Australia.; HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
    Jiamsakul A; Kirby Institute, UNSW, Sydney, Australia.
    Salleh NAM; Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.; Centre of Excellence for Research in AIDS (CERiA), University of Malaya, Kuala Lumpur, Malaysia.
    Choi JY; Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
    Huy BV; National Hospital for Tropical Diseases, Hanoi, Vietnam.
    Yunihastuti E; Faculty of Medicine, Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
    Do CD; Bach Mai Hospital, Hanoi, Vietnam.
    Merati TP; Faculty of Medicine, Udayana University & Sanglah Hospital, Bali, Indonesia.
    Gani YM; Hospital Sungai Buloh, Sungai Buloh, Malaysia.
    Kiertiburanakul S; Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
    Zhang F; Beijing Ditan Hospital, Capital Medical University, Beijing, China.
    Chan YJ; Taipei Veterans General Hospital, Taipei, Taiwan.
    Lee MP; Queen Elizabeth Hospital, Hong Kong, China.
    Chaiwarith R; Research Institute for Health Sciences, Chiang Mai, Thailand.
    Ng OT; Tan Tock Seng Hospital, Tan Tock Seng, Singapore.
    Khusuwan S; Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand.
    Ditangco R; Research Institute for Tropical Medicine, Muntinlupa City, Philippines.
    Kumarasamy N; Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS), VHS-Infectious Diseases Medical Centre, VHS, Chennai, India.
    Sangle S; BJ Government Medical College and Sassoon General Hospital, Pune, India.
    Ross J; TREAT Asia, amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
    Avihingsanon A; HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand.; Tuberculosis Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
    Pokaż więcej
    Corporate Authors:
    TREAT Asia HIV Observational Database (TAHOD) of the International Epidemiology Databases to Evaluate AIDS (IeDEA) Asia-Pacific Group
    Źródło:
    Journal of the International AIDS Society [J Int AIDS Soc] 2021 May; Vol. 24 (5), pp. e25736.
    Typ publikacji:
    Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Anti-HIV Agents*/therapeutic use
    HIV Infections*/drug therapy
    HIV Infections*/epidemiology
    Pharmaceutical Preparations*
    Adult ; Asia/epidemiology ; CD4 Lymphocyte Count ; Cohort Studies ; Female ; Humans ; Longitudinal Studies ; Male ; Treatment Outcome ; Viral Load
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Economic vulnerability and non-initiation of antiretroviral therapy in India: a qualitative study.
    Autorzy:
    Colocci I; Harvard University, Cambridge, USA.
    Perlo J; Harvard University, Cambridge, USA.
    Rajagopal SS; Harvard University, Cambridge, USA.
    Betancourt TS; School of Social Work and Research Program on Children and Adversity, Boston College, Boston, USA.
    Pradeep A; Y.R. Gaitonde Centre for AIDS Research and Education, Chennai, India.
    Mayer KH; Fenway Health, Boston, USA.; Harvard Medical School, Boston, USA.
    Kumarasamy N; Y.R. Gaitonde Centre for AIDS Research and Education, Chennai, India.
    O'Cleirigh C; Behavioral Medicine and Chester M. Pierce, MD Division of Global Psychiatry, Massachusetts General Hospital, Boston, USA.
    Katz IT; Harvard Medical School, Boston, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, USA.; MGH Global Health, Massachusetts General Hospital, Boston, USA.; Harvard Global Health Institute, Cambridge, USA.
    Chan BT; Harvard Medical School, Boston, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, USA.
    Pokaż więcej
    Źródło:
    AIDS care [AIDS Care] 2021 Apr; Vol. 33 (4), pp. 423-427. Date of Electronic Publication: 2020 Jan 13.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Anti-HIV Agents/*therapeutic use
    Antiretroviral Therapy, Highly Active/*economics
    HIV Infections/*drug therapy
    Adult ; CD4 Lymphocyte Count ; Female ; HIV Infections/psychology ; Humans ; India ; Interviews as Topic ; Male ; Poverty ; Private Sector ; Qualitative Research
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Impact of low-level viraemia on virological failure among Asian children with perinatally acquired HIV on first-line combination antiretroviral treatment: a multicentre, retrospective cohort study.
    Autorzy:
    Sudjaritruk T; Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.; Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
    Teeraananchai S; The HIV Netherlands Australia Thailand Research Collaboration, The Thai Red Cross AIDS Research Centre, Bangkok, Thailand.; Department of Statistics, Faculty of Science, Kasetsart University, Bangkok, Thailand.
    Kariminia A; The Kirby Institute, UNSW Australia, Sydney, Australia.
    Lapphra K; Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
    Kumarasamy N; Chennai Antiviral Research and Treatment Clinical Research Site, VHS-Infectious Diseases Medical Centre, VHS, Chennai, India.
    Fong MS; Hospital Likas, Kota Kinabalu, Malaysia.
    Hansudewechakul R; Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand.
    Bunupuradah T; The HIV Netherlands Australia Thailand Research Collaboration, The Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
    Ly PS; National Centre for HIV/AIDS, Dermatology and STDs, Phnom Penh, Cambodia.
    Nallusamy RA; Penang Hospital, Penang, Malaysia.
    Sohn AH; TREAT Asia/amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
    Sirisanthana V; Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
    Pokaż więcej
    Corporate Authors:
    TREAT Asia Pediatric HIV Observational Database of IeDEA Asia-Pacific
    Źródło:
    Journal of the International AIDS Society [J Int AIDS Soc] 2020 Jul; Vol. 23 (7), pp. e25550.
    Typ publikacji:
    Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Viral Load*
    Anti-HIV Agents/*therapeutic use
    HIV Infections/*drug therapy
    HIV Infections/*virology
    Adolescent ; Cambodia ; Child ; Cohort Studies ; Drug Therapy, Combination ; Female ; HIV-1 ; Humans ; Malaysia ; Male ; Proportional Hazards Models ; Retrospective Studies ; Reverse Transcriptase Inhibitors/therapeutic use ; Viremia/drug therapy ; Viremia/virology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Weight-for-age distributions among children with HIV on antiretroviral therapy in the International epidemiology Databases to Evaluate AIDS (IeDEA) multiregional consortium.
    Autorzy:
    Jesson J; Inserm U1027, Université Paul Sabatier Toulouse 3, Toulouse, France. julie_.; Inserm, UMR 1027 - Epidémiologie et analyses en santé publique: risques, maladies chroniques et handicaps - Université Paul Sabatier Toulouse 3, Equipe 2: Axe santé de l'enfant et de l'adolescent en Afrique, 37 Allées Jules Guesde, 31073 Toulouse Cedex 7, France, Toulouse Cedex 7, France. julie_.
    Desmonde S; Inserm U1027, Université Paul Sabatier Toulouse 3, Toulouse, France.
    Yiannoutsos CT; Indiana University, Fairbanks School of Public Health, Indianapolis, IN, USA.
    Patten G; School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
    Malateste K; Inserm U1219, Bordeaux, France.; Bordeaux Population Health Center, Université de Bordeaux, Bordeaux, France.
    Duda SN; Vanderbilt University Medical Center, Nashville, TN, USA.
    Kumarasamy N; Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS), VHS-Infectious Diseases Medical Centre, VHS, Chennai, India.
    Yotebieng M; Division of Epidemiology, The Ohio State University, College of Public Health, Columbus, OH, USA.
    Davies MA; School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
    Musick B; Indiana University School of Medicine, Indianapolis, IN, USA.
    Leroy V; Inserm U1027, Université Paul Sabatier Toulouse 3, Toulouse, France.
    Ciaranello A; The Medical Practice Evaluation Center, Boston, MA, USA.; The Division of General Internal Medicine, Department of Medicine, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital, Boston, MA, USA.
    Pokaż więcej
    Corporate Authors:
    IeDEA
    Źródło:
    BMC research notes [BMC Res Notes] 2020 May 24; Vol. 13 (1), pp. 249. Date of Electronic Publication: 2020 May 24.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Acquired Immunodeficiency Syndrome/*drug therapy
    Anti-HIV Agents/*therapeutic use
    HIV Infections/*drug therapy
    Acquired Immunodeficiency Syndrome/epidemiology ; Adolescent ; Africa, Central ; Africa, Eastern ; Africa, Southern ; Age Distribution ; Asia, Southeastern ; Caribbean Region ; Central America ; Child ; Child, Preschool ; Cohort Studies ; Databases, Factual ; Female ; HIV Infections/epidemiology ; Humans ; Infant ; Male ; South America ; World Health Organization
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Feasibility and acceptability of a psychosocial and adherence electronic patient reported outcomes (PROs) system at an HIV care center in southern India.
    Autorzy:
    Sinha N; Harvard University, Cambridge, MA, USA.
    Yang A; Harvard University, Cambridge, MA, USA.
    Pradeep A; Y.R. Gaitonde Centre for AIDS Research and Education, Chennai, India.
    Bhuvaneswari R; Chennai Antiviral Research and Treatment (CART) Clinical Research Site, Chennai, India.
    Kumarasamy N; Chennai Antiviral Research and Treatment (CART) Clinical Research Site, Chennai, India.
    O'Cleirigh C; Fenway Health, Boston, MA, USA.; Behavioral Medicine and Chester M. Pierce, MD Division of Global Psychiatry, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
    Mayer KH; Fenway Health, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
    Chan BT; Harvard Medical School, Boston, MA, USA.; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.
    Pokaż więcej
    Źródło:
    AIDS care [AIDS Care] 2020 May; Vol. 32 (5), pp. 630-636. Date of Electronic Publication: 2019 Sep 18.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Anti-HIV Agents/*administration & dosage
    Data Collection/*methods
    HIV Infections/*drug therapy
    Medication Adherence/*statistics & numerical data
    Patient Acceptance of Health Care/*statistics & numerical data
    Adult ; Feasibility Studies ; Female ; HIV Infections/epidemiology ; Humans ; India/epidemiology ; Interviews as Topic ; Middle Aged ; Patient Reported Outcome Measures ; Risk-Taking ; Substance-Related Disorders/epidemiology ; Surveys and Questionnaires
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    The influence of age-associated comorbidities on responses to combination antiretroviral therapy in older people living with HIV.
    Autorzy:
    Ahn MY; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, South Korea.; Department of Internal Medicine, Seoul Medical Center, Seoul, South Korea.
    Jiamsakul A; The Kirby Institute, UNSW, Sydney, NSW, Australia.
    Khusuwan S; Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand.
    Khol V; National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia.
    Pham TT; Bach Mai Hospital, Hanoi, Vietnam.
    Chaiwarith R; Research Institute for Health Sciences, Chiang Mai, Thailand.
    Avihingsanon A; HIV-NAT/Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
    Kumarasamy N; Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS), YRGCARE Medical Centre, VHS, Chennai, India.
    Wong WW; Taipei Veterans General Hospital, Taipei, Taiwan.
    Kiertiburanakul S; Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
    Pujari S; Institute of Infectious Diseases, Pune, India.
    Nguyen KV; National Hospital for Tropical Diseases, Hanoi, Vietnam.
    Lee MP; Queen Elizabeth Hospital, Hong Kong SAR, China.
    Kamarulzaman A; University Malaya Medical Centre, Kuala Lumpur, Malaysia.
    Zhang F; Beijing Ditan Hospital, Capital Medical University, Beijing, China.
    Ditangco R; Research Institute for Tropical Medicine, Muntinlupa City, Philippines.
    Merati TP; Faculty of Medicine Udayana University & Sanglah Hospital, Bali, Indonesia.
    Yunihastuti E; Faculty of Medicine Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
    Ng OT; Tan Tock Seng Hospital, Singapore City, Singapore.
    Sim BLH; Hospital Sungai Buloh, Sungai Buloh, Malaysia.
    Tanuma J; National Center for Global Health and Medicine, Tokyo, Japan.
    Ratanasuwan W; Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
    Ross J; TREAT Asia, amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
    Choi JY; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
    Pokaż więcej
    Corporate Authors:
    IeDEA Asia-Pacific
    Źródło:
    Journal of the International AIDS Society [J Int AIDS Soc] 2019 Feb; Vol. 22 (2), pp. e25228.
    Typ publikacji:
    Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Anti-HIV Agents/*therapeutic use
    HIV Infections/*drug therapy
    Adult ; Age Factors ; Aged ; Anti-Retroviral Agents/therapeutic use ; Asia/epidemiology ; CD4 Lymphocyte Count ; Comorbidity ; Databases, Factual ; Female ; HIV Infections/epidemiology ; HIV Infections/immunology ; Humans ; Male ; Middle Aged ; Prospective Studies ; Treatment Outcome ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Early suboptimal ART adherence was associated with missed clinical visits in HIV-infected patients in Asia.
    Autorzy:
    Jiamsakul A; a The Kirby Institute , UNSW Sydney , NSW , Australia.
    Kerr SJ; b HIV-NAT, The Thai Red Cross AIDS Research Centre , Bangkok , Thailand.
    Kiertiburanakul S; c Faculty of Medicine Ramathibodi Hospital , Mahidol University , Bangkok , Thailand.
    Azwa I; d University of Malaya Medical Centre , Kuala Lumpur , Malaysia.
    Zhang F; e Beijing Ditan Hospital, Capital Medical University , Beijing , People's Republic of China.
    Chaiwarith R; f Research Institute for Health Sciences , Chiang Mai University , Chiang Mai , Thailand.
    Wong W; g Taipei Veterans General Hospital , Taipei , Taiwan.
    Ly PS; h National Center for HIV/AIDS, Dermatology and STDs , Phnom Penh , Cambodia.; i University of Health Sciences , Phnom Penh , Cambodia.
    Kumarasamy N; j YRGCARE Medical Centre , Chennai , India.
    Ditangco R; k Research Institute for Tropical Medicine , Manila , Philippines.
    Pujari S; l Institute of Infectious Diseases , Pune , India.
    Yunihastuti E; m Working Group on AIDS, Faculty of Medicine , University of Indonesia/Cipto Mangunkusumo Hospital , Jakarta , Indonesia.
    Do CD; n Bach Mai Hospital , Hanoi , Vietnam.
    Merati TP; o Faculty of Medicine , Udayana University & Sanglah Hospital , Bali , Indonesia.
    Nguyen KV; p National Hospital for Tropical Diseases , Hanoi , Vietnam.
    Lee MP; q Queen Elizabeth Hospital , Hong Kong , People's Republic of China.
    Choi JY; r Division of Infectious Diseases, Department of Internal Medicine , Yonsei University College of Medicine , Seoul , South Korea.
    Oka S; s National Center for Global Health and Medicine , Tokyo , Japan.
    Kantipong P; t Chiangrai Prachanukroh Hospital , Chiang Rai , Thailand.
    Sim BLH; u Hospital Sungai Buloh , Sungai Buloh , Malaysia.
    Ng OT; v Department of Infectious Diseases , Tan Tock Seng Hospital , Singapore , Singapore.
    Ross J; w TREAT Asia, amfAR - The Foundation for AIDS Research , Bangkok , Thailand.
    Law M; a The Kirby Institute , UNSW Sydney , NSW , Australia.
    Pokaż więcej
    Corporate Authors:
    TREAT Asia HIV Observational Database (TAHOD); a The Kirby Institute , UNSW Sydney , NSW , Australia.
    Źródło:
    AIDS care [AIDS Care] 2018 Dec; Vol. 30 (12), pp. 1560-1566. Date of Electronic Publication: 2018 Jul 18.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Medication Adherence*
    Anti-HIV Agents/*therapeutic use
    HIV Infections/*drug therapy
    Adult ; Ambulatory Care ; Ambulatory Care Facilities/organization & administration ; Asia ; Female ; Humans ; Income ; Male ; Middle Aged ; Secondary Prevention ; Self Report
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    The treatment outcomes of antiretroviral substitutions in routine clinical settings in Asia; data from the TREAT Asia HIV Observational Database (TAHOD).
    Autorzy:
    Jung IY; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
    Boettiger D; The Kirby Institute, UNSW Sydney, Sydney, Australia.
    Wong WW; Taipei Veterans General Hospital, Taipei, Taiwan.
    Lee MP; Queen Elizabeth Hospital, Hong Kong, China.
    Kiertiburanakul S; Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
    Chaiwarith R; Research Institute for Health Sciences, Chiang Mai, Thailand.
    Avihingsanon A; HIV-NAT/Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
    Tanuma J; National Center for Global Health and Medicine, Tokyo, Japan.
    Kumarasamy N; Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS), YRGCARE Medical Centre, VHS, Chennai, India.
    Kamarulzaman A; University Malaya Medical Centre, Kuala Lumpur, Malaysia.
    Zhang F; Beijing Ditan Hospital, Capital Medical University, Beijing, China.
    Kantipong P; Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand.
    Ng OT; Tan Tock Seng Hospital, Singapore, Singapore.
    Sim BLH; Hospital Sungai Buloh, Sungai Buloh, Malaysia.
    Law M; The Kirby Institute, UNSW Sydney, Sydney, Australia.
    Ross J; TREAT Asia, amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
    Choi JY; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.; AIDS Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
    Pokaż więcej
    Źródło:
    Journal of the International AIDS Society [J Int AIDS Soc] 2017 Dec; Vol. 20 (4).
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Anti-HIV Agents/*therapeutic use
    HIV Infections/*drug therapy
    Adult ; Asia ; Cohort Studies ; Databases, Factual ; Female ; Humans ; Male ; Middle Aged ; Treatment Outcome ; Viral Load/drug effects
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Growing challenges for HIV programmes in Asia: clinic population trends, 2003-2013.
    Autorzy:
    De La Mata NL; a The Kirby Institute , UNSW Australia , Sydney , Australia.
    Kumarasamy N; b YRGCARE Medical Centre , VHS , Chennai , India.
    Ly PS; c National Center for HIV/AIDS , Dermatology & STDs , Phnom Penh , Cambodia.
    Ng OT; d Tan Tock Seng Hospital , Singapore.
    Nguyen KV; e National Hospital for Tropical Diseases , Hanoi , Vietnam.
    Merati TP; f Faculty of Medicine , Udayana University & Sanglah Hospital , Bali , Indonesia.
    Lee MP; g Queen Elizabeth Hospital , Hong Kong SAR , China.
    Do CD; h Bach Mai Hospital , Hanoi , Vietnam.
    Choi JY; i Department of Internal Medicine and AIDS Research Institute , Yonsei University College of Medicine, Severance Hospital , Seoul , South Korea.
    Ross JL; j TREAT Asia, amfAR - The Foundation for AIDS Research , Bangkok , Thailand.
    Law MG; a The Kirby Institute , UNSW Australia , Sydney , Australia.
    Pokaż więcej
    Źródło:
    AIDS care [AIDS Care] 2017 Oct; Vol. 29 (10), pp. 1243-1254. Date of Electronic Publication: 2017 Jan 29.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Antiretroviral Therapy, Highly Active*
    Anti-HIV Agents/*therapeutic use
    HIV Infections/*drug therapy
    Outcome and Process Assessment, Health Care/*methods
    Program Evaluation/*methods
    Viral Load/*drug effects
    Adult ; Asia/epidemiology ; CD4 Lymphocyte Count ; Cohort Studies ; Female ; HIV Infections/epidemiology ; Humans ; Male ; Middle Aged ; Outcome and Process Assessment, Health Care/statistics & numerical data ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052.
    Autorzy:
    Palumbo PJ; Dept. of Pathology, Johns Hopkins Univ. School of Medicine, Baltimore, Maryland, United States of America.
    Wilson EA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
    Piwowar-Manning E; Dept. of Pathology, Johns Hopkins Univ. School of Medicine, Baltimore, Maryland, United States of America.
    McCauley M; Science Facilitation Department, FHI 360, Washington DC, United States of America.
    Gamble T; Science Facilitation Department, FHI 360, Durham, North Carolina, United States of America.
    Kumwenda N; College of Medicine-Johns Hopkins Project, Blantyre, Malawi.
    Makhema J; Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
    Kumarasamy N; CART CRS, YRGCARE Medical Centre, VHS, Chennai, India.
    Chariyalertsak S; Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
    Hakim JG; Dept. of Medicine, Univ. of Zimbabwe, Harare, Zimbabwe.
    Hosseinipour MC; Division of Infectious Diseases, Univ. of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; UNC Project-Malawi, Institute for Global Health and Infectious Diseases, Lilongwe, Malawi.
    Melo MG; Hospital Nossa Senhora da Conceição, Serviço de Infectologia, Porto Alegre, Brazil.
    Godbole SV; National AIDS Research Institute (ICMR), Pune, India.
    Pilotto JH; Hospital Geral de Nova Iguacu and Laboratorio de AIDS e Imunologia Molecular-IOC/Fiocruz, Rio de Janeiro, Brazil.
    Grinsztejn B; Instituto Nacional de Infectologia Evandro Chagas-INI-Fiocruz, Rio de Janeiro, Brazil.
    Panchia R; Univ. of the Witwatersrand, Perinatal HIV Research Unit, Soweto HPTN CRS, Soweto, South Africa.
    Chen YQ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
    Cohen MS; Dept. of Medicine, Univ. of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
    Eshleman SH; Dept. of Pathology, Johns Hopkins Univ. School of Medicine, Baltimore, Maryland, United States of America.
    Fogel JM; Dept. of Pathology, Johns Hopkins Univ. School of Medicine, Baltimore, Maryland, United States of America.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2017 May 08; Vol. 12 (5), pp. e0177281. Date of Electronic Publication: 2017 May 08 (Print Publication: 2017).
    Typ publikacji:
    Journal Article; Multicenter Study; Randomized Controlled Trial
    MeSH Terms:
    Anti-HIV Agents/*therapeutic use
    HIV/*classification
    HIV Infections/*drug therapy
    CD4 Lymphocyte Count ; Child ; Cohort Studies ; Female ; HIV Infections/virology ; Humans ; Male ; Treatment Outcome ; Viral Load
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings.
    Autorzy:
    Kiertiburanakul S; Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 270 Rama VI Road, Bangkok, 10400 Thailand.
    Boettiger D; The Kirby Institute, University of New South Wales, Sydney, Australia.
    Ng OT; Tan Tock Seng Hospital, Singapore, Singapore.
    Van Kinh N; National Hospital of Tropical Diseases, Hanoi, Vietnam.
    Merati TP; Department of Medicine, Faculty of Medicine, Udayana University & Sanglah Hospital, Bali, Indonesia.
    Avihingsanon A; HIV-NAT/Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
    Wong WW; Taipei Veterans General Hospital, Taipei, Taiwan.
    Lee MP; Queen Elizabeth Hospital, Hong Kong, China.
    Chaiwarith R; Research Institute for Health Sciences, Chiang Mai, Thailand.
    Kamarulzaman A; University Malaya Medical Centre, Kuala Lumpur, Malaysia.
    Kantipong P; Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand.
    Zhang F; Beijing Ditan Hospital, Capital Medical University, Beijing, China.
    Choi JY; Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
    Kumarasamy N; Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS), YRGCARE Medical Centre, VHS, Chennai, India.
    Ditangco R; Research Institute for Tropical Medicine, Manila, Philippines.
    Cuong DD; Bach Mai Hospital, Hanoi, Vietnam.
    Oka S; National Center for Global Health and Medicine, Tokyo, Japan.
    Sim BLH; Hospital Sungai Buloh, Sungai Buloh, Malaysia.
    Ratanasuwan W; Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
    Ly PS; National Center for HIV/AIDS, Dermatology & STDs, University of Health Sciences, Phnom Penh, Cambodia.
    Yunihastuti E; Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
    Pujari S; Institute of Infectious Diseases, Pune, India.
    Ross JL; TREAT Asia, amfAR, The Foundation for AIDS Research, Bangkok, Thailand.
    Law M; The Kirby Institute, University of New South Wales, Sydney, Australia.
    Sungkanuparph S; Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 270 Rama VI Road, Bangkok, 10400 Thailand.
    Pokaż więcej
    Corporate Authors:
    TREAT Asia HIV Observational Databases (TAHOD)
    Źródło:
    AIDS research and therapy [AIDS Res Ther] 2017 May 05; Vol. 14, pp. 27. Date of Electronic Publication: 2017 May 05 (Print Publication: 2017).
    Typ publikacji:
    Evaluation Study; Journal Article; Multicenter Study
    MeSH Terms:
    Decision Support Techniques*
    Viral Load*
    Anti-HIV Agents/*therapeutic use
    Antiretroviral Therapy, Highly Active/*methods
    HIV Infections/*drug therapy
    HIV Infections/*virology
    RNA, Viral/*blood
    Adult ; Asia ; Developing Countries ; Dideoxynucleosides/therapeutic use ; Female ; Humans ; Male ; Prospective Studies ; Rilpivirine/therapeutic use
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Renal Dysfunction during Tenofovir Use in a Regional Cohort of HIV-Infected Individuals in the Asia-Pacific.
    Autorzy:
    Tanuma J; AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
    Jiamsakul A; The Kirby Institute, UNSW Australia, Sydney, Australia.
    Makane A; Institute of Infectious Diseases, Pune, India.
    Avihingsanon A; The Netherland Australia Thailand Research Collaboration/Thai Red Cross AIDS Research Centre, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
    Ng OT; Department of Infectious Disease and Communicable Disease Centre, Tan Tock Seng Hospital, Singapore, Singapore.
    Kiertiburanakul S; Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
    Chaiwarith R; Research Institute for Health Sciences, Chiang Mai, Thailand.
    Kumarasamy N; Chennai Antiviral Research and Treatment Clinical Research Site, Y.R. Gaitonde Centre for AIDS Research and Education, Chennai, India.
    Nguyen KV; National Hospital of Tropical Diseases, Hanoi, Vietnam.
    Pham TT; Infectious Disease Department, Bach Mai Hospital, Hanoi, Vietnam.
    Lee MP; Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China.
    Ditangco R; Department of Health, Research Institute for Tropical Medicine, Manila, Philippines.
    Merati TP; Faculty of Medicine, Udayana University & Sanglah Hospital, Bali, Indonesia.
    Choi JY; Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
    Wong WW; Infectious Diseases and AIDS Unit, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
    Kamarulzaman A; Faculty of Medicine, University Malaya Medical Centre, Kuala Lumpur, Malaysia.
    Yunihastuti E; Faculty of Medicine, University of Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
    Sim BL; Department of Medicine, Hospital Sungai Buloh, Sungai Buloh, Malaysia.
    Ratanasuwan W; Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
    Kantipong P; Department of Medicine, Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand.
    Zhang F; Beijing Ditan Hospital, Capital Medical University, Beijing, China.
    Mustafa M; Medical Department, Hospital Raja Perempuan Zainab II, Kota Bharu, Malaysia.
    Saphonn V; National Center for HIV/AIDS, Dermatology & STDs, University of Health Sciences, Phnom Penh, Cambodia.
    Pujari S; Institute of Infectious Diseases, Pune, India.
    Sohn AH; TREAT Asia, amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
    Pokaż więcej
    Corporate Authors:
    TREAT Asia HIV Observational Databases (TAHOD)
    Źródło:
    PloS one [PLoS One] 2016 Aug 25; Vol. 11 (8), pp. e0161562. Date of Electronic Publication: 2016 Aug 25 (Print Publication: 2016).
    Typ publikacji:
    Journal Article; Observational Study
    MeSH Terms:
    Anti-HIV Agents/*adverse effects
    HIV Infections/*drug therapy
    Kidney/*drug effects
    Kidney/*physiopathology
    Kidney Diseases/*chemically induced
    Tenofovir/*adverse effects
    Adult ; Anti-HIV Agents/therapeutic use ; Creatinine/blood ; Databases, Factual ; Female ; Glomerular Filtration Rate ; Humans ; Male ; Middle Aged ; Poisson Distribution ; Proportional Hazards Models ; Prospective Studies ; Risk Factors ; Tenofovir/therapeutic use
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Factors associated with suboptimal adherence to antiretroviral therapy in Asia.
    Autorzy:
    Jiamsakul A; The Kirby Institute, UNSW Australia, Sydney, Australia; .
    Kumarasamy N; YRGCARE Medical Centre, Chennai, India.
    Ditangco R; Research Institute for Tropical Medicine, Manila, Philippines.
    Li PC; Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China.
    Phanuphak P; Faculty of Medicine, Chulalongkorn University and HIV-NAT/Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
    Sirisanthana T; Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
    Sungkanuparph S; Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
    Kantipong P; Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand.
    K C Lee C; Hospital Sungai Buloh, Sungai Buloh, Malaysia.
    Mustafa M; Hospital Raja Perempuan Zainab II, Kota Bharu, Malaysia.
    Merati T; Udayana University, Sanglah Hospital, Bali, Indonesia.
    Kamarulzaman A; University of Malaya Medical Center, Kuala Lumpur, Malaysia.
    Singtoroj T; TREAT Asia, amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
    Law M; The Kirby Institute, UNSW Australia, Sydney, Australia.
    Pokaż więcej
    Corporate Authors:
    TREAT Asia Studies to Evaluate Resistance Monitoring Study (TASER-M)
    Źródło:
    Journal of the International AIDS Society [J Int AIDS Soc] 2014 May 16; Vol. 17, pp. 18911. Date of Electronic Publication: 2014 May 16 (Print Publication: 2014).
    Typ publikacji:
    Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Anti-HIV Agents/*therapeutic use
    HIV Infections/*drug therapy
    Medication Adherence/*statistics & numerical data
    Adult ; Asia/epidemiology ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Risk Factors ; Self Report ; Viral Load/statistics & numerical data ; Visual Analog Scale
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV-positive patients.
    Autorzy:
    Kiertiburanakul S; Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; .
    Boettiger D; The Kirby Institute, University of New South Wales, Kensington, NSW, Australia.
    Lee MP; Queen Elizabeth Hospital, Hong Kong, China SAR.
    Omar SF; University of Malaya Medical Centre, Kuala Lumpur, Malaysia.
    Tanuma J; National Center for Global Health and Medicine, Toyama Shinjuku-ku, Tokyo, Japan.
    Ng OT; Tan Tock Seng Hospital, Singapore.
    Durier N; TREAT Asia, amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
    Phanuphak P; HIV-NAT/Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
    Ditangco R; Research Institute for Tropical Medicine, Manila, Philippines.
    Chaiwarith R; Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
    Kantipong P; Chiang Rai Prachanukroh Hospital, Chiang Rai, Thailand.
    Lee CK; Hospital Sungai Buloh, Sungai Buloh, Malaysia.
    Mustafa M; Hospital Raja Perempuan Zainab II, Kota Bharu, Malaysia.
    Saphonn V; National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia.
    Ratanasuwan W; Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
    Merati TP; Faculty of Medicine, Udayana University & Sanglah Hospital, Bali, Indonesia.
    Kumarasamy N; YRG Centre for AIDS Research and Education, Chennai, India.
    Wong WW; Taipei Veterans General Hospital and AIDS Prevention and Research Centre, National Yang-Ming University, Taipei, Taiwan.
    Zhang F; Beijing Ditan Hospital, Beijing, China.
    Pham TT; Bach Mai Hospital, Hanoi, Vietnam.
    Pujari S; Institute of Infectious Diseases, Pune, India.
    Choi JY; Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
    Yunihastuti E; Working Group on AIDS Faculty of Medicine, University of Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
    Sungkanuparph S; Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
    Pokaż więcej
    Corporate Authors:
    TREAT Asia HIV Observational Databases (TAHOD)
    TREAT Asia Studies to Evaluate Resistance (TASER)
    Źródło:
    Journal of the International AIDS Society [J Int AIDS Soc] 2014 Mar 14; Vol. 17, pp. 18804. Date of Electronic Publication: 2014 Mar 14 (Print Publication: 2014).
    Typ publikacji:
    Journal Article; Multicenter Study; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Anti-HIV Agents/*therapeutic use
    CD4 Lymphocyte Count/*statistics & numerical data
    HIV Infections/*drug therapy
    Adult ; Asia/epidemiology ; Delayed Diagnosis/statistics & numerical data ; Female ; HIV Infections/immunology ; HIV Infections/mortality ; Humans ; Male ; Middle Aged ; Prospective Studies ; Time Factors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Dropout from care among HIV-infected patients enrolled in care at a tertiary HIV care center in Chennai, India.
    Autorzy:
    Blutinger EJ; a School of Medicine and Health Sciences , George Washington University , Washington , DC , USA.
    Solomon S
    Srikrishnan AK
    Thamburaj E
    Kumarasamy N
    Balakrishnan P
    Anand S
    Ganesh AK
    Solomon SS
    Pokaż więcej
    Źródło:
    AIDS care [AIDS Care] 2014; Vol. 26 (12), pp. 1500-5. Date of Electronic Publication: 2014 Jul 11.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Ambulatory Care/*statistics & numerical data
    Anti-HIV Agents/*therapeutic use
    HIV Infections/*drug therapy
    HIV Infections/*epidemiology
    Patient Dropouts/*statistics & numerical data
    Tertiary Care Centers/*statistics & numerical data
    Adult ; Female ; Follow-Up Studies ; Humans ; India/epidemiology ; Male ; Middle Aged ; Retrospective Studies ; Time Factors ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Factors influencing adherence to anti-retroviral treatment in children with human immunodeficiency virus in South India--a qualitative study.
    Autorzy:
    Paranthaman K; Department of Public Health, University of Oxford, Oxford, UK. karthikeyan_ />Kumarasamy N
    Bella D
    Webster P
    Pokaż więcej
    Źródło:
    AIDS care [AIDS Care] 2009 Aug; Vol. 21 (8), pp. 1025-31.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Anti-HIV Agents/*therapeutic use
    HIV Infections/*drug therapy
    Adult ; Aged ; Caregivers ; Child ; Child, Preschool ; Family Relations ; Female ; Humans ; India ; Infant ; Male ; Medication Adherence/statistics & numerical data ; Middle Aged ; Socioeconomic Factors ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-20 z 20

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies